Connor, Clark & Lunn Investment Management (CC&L)’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.99M | Buy |
|
|||||
|
2025
Q2 | $6.29M | Buy |
|
|||||
|
2025
Q1 | $4.53M | Buy |
|
|||||
|
2024
Q4 | $8.63M | Buy |
|
|||||
|
2024
Q3 | $6.96M | Sell |
|
|||||
|
2024
Q2 | $5.75M | Buy |
|
|||||
|
2024
Q1 | $1.79M | Buy |
|
|||||
|
2023
Q4 | $505K | Buy |
|
|||||
|
2023
Q3 | $712K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $475K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $4.07M | Buy |
|
|||||
|
2020
Q2 | $1.77M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.02M | Buy |
|
|||||
|
2015
Q3 | $1.15M | Buy |
|
|||||
|
2015
Q2 | $201K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.51M | Buy |
|
|||||
|
2013
Q4 | $736K | Sell |
|
|||||
|
2013
Q3 | $603K | Buy |
|
|||||
|
2013
Q2 | $382K | Buy |
|